Paul C. Canniff

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

Angela Nguyen, John C. Kath, Douglas C. Hanson et al. · Molecular Pharmacology · 1996 · 99 citations

UK‐78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage‐gated potassium channel and inhibits human T cell activation

Douglas C. Hanson, Angela Nguyen, Robert J. Mather et al. · British Journal of Pharmacology · 1999 · 64 citations · Full text

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

Paul J. Silver, Alex L. Harris, Paul C. Canniff et al. · Journal of Cardiovascular Pharmacology · 1989 · 58 citations

Cardiac Muscle, Muscle Function, Positive Inotropy Mediated +22

Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle

Paul J. Silver, Alex L. Harris, Paul C. Canniff et al. · Journal of Cardiovascular Pharmacology · 1989 · 55 citations

Camp System, Cardiac Muscle, Cardiomyopathy +15

Preclinical in vitro characterization of anti-CTLA4 therapeutic antibody CP-675,206.

Douglas C. Hanson, Paul C. Canniff, Michael J. Primiano et al. · Cancer Research · 2004 · 37 citations

Vitro Characterization, Apoptosis, Immunology +19